FDA calls for more safety data, patient counseling for Essure

The Food and Drug Administration has ordered Bayer to conduct a 2,000-patient postmarketing study of the Essure implantable birth control device, to explore the risks it may pose to some women and...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news